Atea Pharmaceuticals Inc (AVIR) — Capital Reinvestment Ratio
Atea Pharmaceuticals Inc (AVIR) has a Capital Reinvestment Ratio of 0.00x as of September 2021, meaning it reinvests 0% of its operating cash flow ($22.60 Million) in capital expenditures ($4.00K). See net asset quality index of Atea Pharmaceuticals Inc to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Atea Pharmaceuticals Inc Capital Reinvestment Ratio (2020–2020)
This chart tracks Atea Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. Check Atea Pharmaceuticals Inc (AVIR) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Atea Pharmaceuticals Inc (2020–2020)
Year-by-year Capital Reinvestment Ratio for Atea Pharmaceuticals Inc from 2020 to 2020. For live market cap and broader valuation context, see Atea Pharmaceuticals Inc (AVIR) total market value.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.00x | $296.73 Million | $26.00K | — |